Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Cariboo Gold History Inspires Modern Discovery (CSE:GCC) (OTC:GCCFF) (click to learn more) Southern Energy Corp. Completes US$23.5 Million Financings and Royalty Sale (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Bullboard - Stock Discussion Forum Kyntra Bio Inc KYNB

Healthcare Biotechnology
Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan... see more

Bullboard (NDAQ:KYNB)

View:
User Avatar Image
(187)
•••
  • coolfooldumbguyX
Post by coolfooldumbguyon Mar 24, 2025 2:56pm

Using technical analysis for this stock.

It looks like the worst is over for this one and it will be going up again in the future, after all of the restructuring,and all of the insider buying by the directors,it should be doing well for all ...more  
70
User Avatar Image
(59)
•••
  • NibinatorX
Post by Nibinatoron Jan 30, 2024 12:32pm

BUY BUY BUY BUY BUY

Bought at 1.80 selling at 2.45
77
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Oct 12, 2021 8:13am

4 BIOTECH STOCKS INSIDERS ARE SELLING!

$FGEN $DCPH $RAPT $SGTX  Insider selling cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the buying and selling activities to gauge a ...more  
190
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Aug 24, 2021 7:39am

4 BIOTECH STOCKS FACING FDA REJECTION!

4 BIOTECH STOCKS FACING FDA REJECTION! Is it a full stop or a pause to their journey? SESN FGEN SPPI ARDX Read More: https://www.aviseanalytics.com/4-biotech-stocks-facing-fda-rejection/ Click ...more  
153
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Podcasts